Zhu H - Search Results

1

CD4⁺CD57⁺ senescent T cells as promoters of systemic lupus erythematosus pathogenesis and the therapeutic potential of senolytic BCL-2 inhibitor.

Jiang J, Yang M, Zhu H, Long D, He Z, Liu J, He L, Tan Y, Akbar AN, Reddy V, Zhao M, Long H, Wu H, Lu Q. Jiang J, et al. Among authors: zhu h. Eur J Immunol. 2024 Jul;54(7):e2350603. doi: 10.1002/eji.202350603. Epub 2024 May 16. Eur J Immunol. 2024. PMID: 38752316

2

The Pathogenic Role of Dysregulated Epigenetic Modifications in Autoimmune Diseases.

Wu H, Chen Y, Zhu H, Zhao M, Lu Q. Wu H, et al. Among authors: zhu h. Front Immunol. 2019 Sep 27;10:2305. doi: 10.3389/fimmu.2019.02305. eCollection 2019. Front Immunol. 2019. PMID: 31611879 Free PMC article. Review.

3

The complex role of AIM2 in autoimmune diseases and cancers.

Zhu H, Zhao M, Chang C, Chan V, Lu Q, Wu H. Zhu H, et al. Immun Inflamm Dis. 2021 Sep;9(3):649-665. doi: 10.1002/iid3.443. Epub 2021 May 20. Immun Inflamm Dis. 2021. PMID: 34014039 Free PMC article. Review.

4

Skin CD4⁺ Trm cells distinguish acute cutaneous lupus erythematosus from localized discoid lupus erythematosus/subacute cutaneous lupus erythematosus and other skin diseases.

Zhao Z, Zhu H, Li Q, Liao W, Chen K, Yang M, Long D, He Z, Zhao M, Wu H, Lu Q. Zhao Z, et al. Among authors: zhu h. J Autoimmun. 2022 Apr;128:102811. doi: 10.1016/j.jaut.2022.102811. Epub 2022 Mar 9. J Autoimmun. 2022. PMID: 35278775

5

RNA N6-methyladenosine methylation and skin diseases.

Yu Y, Lu S, Jin H, Zhu H, Wei X, Zhou T, Zhao M. Yu Y, et al. Among authors: zhu h. Autoimmunity. 2023 Dec;56(1):2167983. doi: 10.1080/08916934.2023.2167983. Autoimmunity. 2023. PMID: 36708146 Free article. Review.

6

m⁶A methyltransferase METTL3 programs CD4⁺ T-cell activation and effector T-cell differentiation in systemic lupus erythematosus.

Lu S, Wei X, Zhu H, Hu Z, Zheng M, Wu J, Zhao C, Yang S, Feng D, Jia S, Zhao H, Zhao M. Lu S, et al. Among authors: zhu h. Mol Med. 2023 Apr 3;29(1):46. doi: 10.1186/s10020-023-00643-4. Mol Med. 2023. PMID: 37013484 Free PMC article.

7

Topical application of a BCL-2 inhibitor ameliorates imiquimod-induced psoriasiform dermatitis by eliminating senescent cells.

Zhu H, Jiang J, Yang M, Zhao M, He Z, Tang C, Song C, Zhao M, Akbar AN, Reddy V, Pan W, Li S, Tan Y, Wu H, Lu Q. Zhu H, et al. J Dermatol Sci. 2024 Aug;115(2):54-63. doi: 10.1016/j.jdermsci.2024.06.002. Epub 2024 Jun 18. J Dermatol Sci. 2024. PMID: 38960840

8

Topical administration of a BCL-2 inhibitor alleviates cutaneous lupus erythematosus.

Jiang J, Zhu H, Yang M, Yang B, Wu H, Lu Q. Jiang J, et al. Among authors: zhu h. Int Immunopharmacol. 2024 Dec 5;142(Pt B):113132. doi: 10.1016/j.intimp.2024.113132. Epub 2024 Sep 16. Int Immunopharmacol. 2024. PMID: 39288621

9

Case report: a case of AL amyloidosis with spontaneous giant retroperitoneal hematoma.

Sheng Y, Zhu H. Sheng Y, et al. Among authors: zhu h. Int J Emerg Med. 2024 Dec 27;17(1):200. doi: 10.1186/s12245-024-00801-3. Int J Emerg Med. 2024. PMID: 39731001

10

Immunogenicity and safety of live attenuated influenza vaccine in children aged 3-17 years in China.

Ai L, Gao Z, Lv H, Zhang J, Xu N, Zhao H, Lu Q, Zhu H, Shi N, Wei W, Liu D, Yu Q. Ai L, et al. Among authors: zhu h. Vaccine. 2024 Dec 26;46:126653. doi: 10.1016/j.vaccine.2024.126653. Online ahead of print. Vaccine. 2024. PMID: 39729925

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

30,150 results

Search Page

Filters